Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Jan. 01, 2022	Dec. 26, 2020
Cash flows from operating activities
Net income	$ 161,246	$ 51,013
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	9,869	8,994
Amortization of intangible assets	5,664	4,082
Amortization of deferred financing fees	599	380
Equity-based compensation	6,134	4,625
Deferred taxes	5,942	3,251
Loss (gain) on disposal of property, plant, and equipment	696	(75)
Foreign currency transaction loss (gain)	55	(421)
Change in assets and liabilities:
Accounts receivable	11,419	4,577
Inventories	(19,133)	(3,388)
Prepaids and other assets	(22,954)	(2,239)
Accounts payable	(13,076)	(284)
Accrued expenses and other liabilities	17,945	33,301
Net cash provided by operating activities	164,406	103,816
Cash flows from investing activities
Additions to property, plant, and equipment	(22,784)	(4,235)
Cash paid for acquisition	(207)
Proceeds from maturity of Company owned life insurance policy		1,186
Proceeds from disposal of property, plant, and equipment	70	1,836
Net cash used in investing activities	(22,921)	(1,213)
Cash flows from financing activities
Changes in floor plan financing, net	8,583	(8,318)
Payments on deferred financing fees	(1,130)
Payments on revolving debt facility	(26,900)	(38,000)
Stock option exercises	1,099	67
Tax payments for equity-based compensation	(3,007)	(1,687)
Net cash used in financing activities	(21,355)	(47,938)
Effect of exchange rate changes on cash and cash equivalents	(578)	2,940
Net increase in cash and cash equivalents	119,552	57,605
Cash and cash equivalents at beginning of period	262,581	209,455
Cash and cash equivalents at end of period	$ 382,133	$ 267,060